Transcatheter aortic valve replacement (TAVR) has become an established therapeutic
option for patients with symptomatic, severe aortic valve stenosis at increased surgical risk …

Background Subclinical leaflet thrombosis, characterized by hypoattenuated leaflet
thickening (HALT) and reduced leaflet motion observed on 4-dimensional computed …

Background Subclinical leaflet thrombosis has been reported after bioprosthetic aortic valve
replacement, characterized using 4-dimensional computed tomographic imaging by …

Background: Surgical aortic valve replacement using conventional biological valves (CBVs)
is the standard of care for treatment of old patients with aortic valve disease. Recently, rapid …

Since the inception of transcatheter aortic valve replacement (TAVR), there have been
significant reductions in complications due to improvements of transcatheter heart valve …

OBJECTIVES To compare procedural and in-hospital outcomes of patients undergoing
sutureless (Perceval, Livanova PLC, London, UK) and rapid deployment (Intuity Elite …

Degenerative valve disease is on the rise with greater than 100,000 valve operations
performed in the US alone per year. The majority of those procedures employ tissue …

In recent years, the phenomenon of subclinical leaflet thrombosis (SLT) in patients who have
undergone transcatheter aortic valve implantation has become increasingly relevant. Hypo …

Bioprosthetic aortic valve thrombosis is frequently detected after transcatheter and surgical
aortic valve replacement due to advances in cardiac computed tomography angiography …

Bioprosthetic heart valves (BPHVs) have fundamentally changed the treatment of valvular
heart disease. Despite the continuous progress of BPHVs, from early valve designs for use …